Robert Shapiro, AHS 2021: COVID-19 Incidence and Mortality Among Individuals with Migraine

touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine.

The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency of COVID-19 Symptoms, but Lower COVID-19-Associated Health Care Resource Utilization Rates’ was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 June 2021.

Questions:

1. What is known about the risk of COVID-19 incidence and mortality among individuals with migraine? (0:16)
2. Could you give us a brief overview of your National Health and Wellness Survey study and its findings? (2:44)
3. What hypotheses have been proposed to explain these findings? (4:49)

Disclosures: Robert Shapiro has provided research consultation for Eli Lilly and Lundbeck within the past 12 months.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.

Filmed as a highlight of AHS Virtual Annual Scientific Meeting 2021.